RESTYLANE® DEFYNE with Lidocaine

Key Uses of Restylane Defyne with Lidocaine

• Smoothing deep facial wrinkles, including nasolabial folds and marionette lines.
• Enhancing facial contours, particularly for chin augmentation and contouring.
• Restoring volume and fullness in areas with significant volume loss.
• Correcting facial asymmetry to create a harmonious appearance.

Manufacturing Information for Restylane Defyne with Lidocaine

Restylane Defyne with Lidocaine is manufactured by Galderma, a renowned global leader in dermatological solutions. Galderma is dedicated to innovative and effective skin health products. In addition to Restylane Defyne, the company produces other well-known products in the Restylane range, such as Restylane Refyne and Restylane Lyft Lidocaine 1ml. Medical professionals can buy Restylane dermal fillers online at Kinami Health shop at wholesale and competitive prices.

Benefits and Results of Using Restylane Defyne with Lidocaine

Restylane Defyne with Lidocaine offers numerous benefits and impressive results, making it a preferred dermal fillers choice among medical professionals:

• Advanced technology: Uses XpresHAn Technology™ for flexible and supportive gel integration.
• Comfortable treatment: Contains Lidocaine to minimise pain and discomfort during the procedure.
• Versatile applications: Suitable for treating deep facial wrinkles, and folds, and enhancing facial contours.
• Natural-looking results: Smooths deep lines and wrinkles while maintaining natural facial expressions.
• Long-lasting effects: Provides durable correction, lasting for months.
• High patient satisfaction: Consistently delivers results that meet patient expectations.

Restylane Defyne with Lidocaine Main Ingredients and Device Properties

• Hyaluronic Acid (20 mg/ml): Restores volume and provides hydration.
• Lidocaine (0.3%): Local anesthetic for pain relief and comfort during treatment.
• Crosslinked hyaluronic acid gel: Offers flexible and natural-looking results.
• XpresHAn Technology™: Enhances the gel’s adaptability to facial movements, ensuring a smooth integration into the skin.

Included Items or Accessories

Restylane Defyne with Lidocaine comes with essential accessories to facilitate its use:

• 1 pre-filled syringe (1ml) of Restylane Defyne with Lidocaine
• 2 sterile 27G1/2″ needles
• Package insert
• Patient record labels

Administration Method for Restylane Defyne with Lidocaine

The mode of administration for Restylane Defyne with Lidocaine involves the following stages:

• Pre-procedure: Disinfect the treatment area thoroughly. Apply a topical anesthetic if necessary.
• During the procedure: Inject the filler slowly and evenly into the mid-to-deep dermis.
• Post-procedure: Gently massage the area to ensure even distribution and advise patients on aftercare.

Post-Treatment Care

Proper post-treatment care enhances the results and minimizes complications:

• Avoid strenuous activities for 24-48 hours.
• Refrain from excessive sun or heat exposure, such as saunas or hot tubs.
• Avoid touching or massaging the treated area for 6 hours.
• Use a gentle cleanser and moisturizer for skincare.
• Schedule a follow-up appointment if necessary.

The effects of Restylane Defyne with Lidocaine typically last up to 12 months. Regular touch-ups ensure the longevity of the achieved enhancements and patient satisfaction.

Potential Side Effects

Like all medical devices, Restylane Defyne with Lidocaine may cause some side effects, although it is generally well-tolerated:

• Common side effects: Redness, swelling, bruising, tenderness, and sensitivity.
• Rare side effects: Infection, allergic reaction, granuloma formation, asymmetry, necrosis, and nerve damage.

Contraindications for the Treatment

Certain individuals should not receive Restylane Defyne with Lidocaine:

• Underaged patients.
• Pregnant or breastfeeding women.
• Individuals with severe allergies.
• Patients with bleeding disorders.
• People with skin infections.
• Individuals with a history of anaphylaxis.
• Patients on certain therapies, like anticoagulant medication or cancer treatment.
• Patients with autoimmune diseases.